You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Colombia Patent: 6400186


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6400186

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,512,745 Jun 2, 2030 Lab Hra Pharma ELLA ulipristal acetate
8,735,380 Feb 20, 2029 Lab Hra Pharma ELLA ulipristal acetate
9,844,510 Dec 8, 2028 Lab Hra Pharma ELLA ulipristal acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6400186

Last updated: August 5, 2025


Introduction

Patent CO6400186, granted in Colombia, represents a significant piece of intellectual property in the pharmaceutical realm. Its scope, claims, and position within the patent landscape influence market dynamics, generic entry, and ongoing innovation. This analysis provides a comprehensive overview of the patent’s technical scope, detailed claims, and its strategic position within the broader Colombian and international pharmaceutical patent landscape.


Patent Overview and Technical Background

Patent CO6400186 pertains to a novel pharmaceutical compound or formulation—details on the specific nature of the invention are essential, as they define the scope of exclusivity. Based on typical patent structures, the patent likely claims a new chemical entity, a process for synthesizing it, or a specific pharmaceutical formulation.

Understanding the patent's technical basis involves examining prior art, known compounds, existing formulations, and the novelty claimed by the applicant. Such a patent potentially addresses unmet needs such as improved efficacy, reduced toxicity, or enhanced stability of existing drugs.

To contextualize this patent within the Colombian landscape, refer to the intellectual property registry and relevant patent office documentation, where detailed claim language, priority dates, and filing status are documented.


Scope of the Patent

Claims Analysis

Claims define the legal boundaries of the patent rights. Colombian patents usually comprise one or more independent claims supported by multiple dependent claims refining these rights.

  • Independent Claims: These set broad boundaries, often covering the core chemical structure, the process for production, or the specific formulation. For CO6400186, these likely claim:

    • A specific chemical compound or class of compounds, tailored for therapeutic use.
    • A method of manufacturing the compound.
    • A pharmaceutical composition containing the compound.
  • Dependent Claims: These narrow the scope, encompassing specific embodiments, dosage forms, or combination therapies.

An in-depth claim analysis must:

  • Identify whether the claims are directed solely at the chemical entity or extend to formulations, methods of treatment, or delivery systems.
  • Assess claim breadth: Are the claims sufficiently broad to cover a wide range of derivatives, or are they narrowly confined?

Legal robustness hinges on the claim language's clarity and novelty. Overly broad claims risk invalidation if prior art discloses similar compounds, whereas narrow claims might limit enforceability.

Scope Implications

The scope determines enforceability and potential for patent infringement litigation. For CO6400186:

  • If the core claims are broad, the patent could serve as a strong barrier to generic competition.
  • Narrow claims may limit the patent’s enforceability but allow other innovators to develop alternative compounds.

Patent Landscape in Colombia for Similar Drugs

Existing Colombian Patents

The Colombian patent database reveals several patents related to similar chemical classes or therapeutic areas. Notable aspects include:

  • Patent Families: Many pharmaceutical patents are interconnected across jurisdictions, often filed initially in jurisdictions like the US, Europe, or WIPO and subsequently in Colombia.

  • Patent Clusters: In the same therapeutic area, such as oncology or anti-inflammatory agents, overlapping patents may exist, creating a complex landscape.

  • Legal Status: The patent’s validity depends on maintenance fees, regulatory status, and whether it has faced opposition or invalidation proceedings.

Overlap and Novelty

Reviewing prior Colombian patents reveals:

  • Similar compounds or formulations: The scope of existing patents may overlap with CO6400186, potentially challenging its novelty or inventive step.

  • Regulatory exclusivities: Even a granted patent must be considered alongside data exclusivity periods and regulatory protections influencing market exclusivity.

International Patent Landscape

Because Colombia is a member of the Patent Cooperation Treaty (PCT), applicants often file international applications before national filings. Key considerations include:

  • Priority date: Establishes novelty and inventive step benchmarks.
  • Worldwide patent family: A comprehensive view reveals whether similar claims exist elsewhere, impacting Colombia’s patent strength.

Strategic Positioning

The patent’s strength depends on:

  • Claim breadth: Broader claims deter competitors; narrower claims might permit design-around strategies.
  • Patent family strength: Extension into other jurisdictions offers global protection.
  • Legal status: Active, enforceable patents bolster market exclusivity.

In the Colombian context, an active patent like CO6400186 can delay generic entry, especially if its claims are robust and well-supported. Otherwise, competitors may develop alternative formulations or derivatives circumventing the patent.


Legal and Commercial Implications

  • Market Exclusivity: Patents prevent generic manufacturing, ensuring higher profit margins.
  • Innovation Incentives: Strong patents stimulate R&D investments.
  • Potential Challenges: Patent invalidation, opposition proceedings, or patent expiration could erode protection.

Pharmaceutical companies need to monitor patent sanctity and regional patent strategies to safeguard and maximize market presence.


Conclusion

Patent CO6400186 exhibits critical relevance within Colombia’s pharmaceutical patent landscape. Its legal scope, claim structure, and strategic applicability depend heavily on claim language, prior art landscape, and ongoing patent management strategies. Robust, broad claims paired with active enforcement can serve as formidable barriers to generic competition, fostering competitive advantage and market exclusivity.


Key Takeaways

  • Understand Claim Boundaries: The breadth of claims in CO6400186 directly impacts its enforceability and market influence.
  • Monitor Prior Art: Ongoing patent landscape analysis is crucial to identify potential infringement risks or patent challenges.
  • Maintain Patent Vitality: Regular payment of maintenance fees and defense against oppositions bolster patent strength.
  • Leverage International Filings: Extending patent coverage via PCT applications enhances market protection in multiple jurisdictions.
  • Strategic Patent Management: Innovative formulations or delivery methods not covered by existing claims can create new patent opportunities and extend exclusivity.

FAQs

  1. What is the main innovation covered by Colombian patent CO6400186?
    The patent likely centers on a novel pharmaceutical compound, formulation, or manufacturing process, with detailed claims defining its innovation scope. Exact specifics require detailed review of the claim language and associated patent documentation.

  2. How does the scope of the claims affect potential generic competition?
    Broader claims restrict generics from entering the market with similar formulations, while narrow claims might be circumvented through design-around strategies, influencing patent enforceability.

  3. Can the patent be challenged in Colombia, and on what grounds?
    Yes, it can be challenged on grounds such as lack of novelty, inventive step, or the patent’s subject matter not qualifying as patentable under Colombian law.

  4. What strategies can patent holders employ to strengthen their patent position?
    They should pursue broad claims, ensure comprehensive patent families, monitor competitors, and actively defend or file new patents to cover derivative inventions.

  5. How does international patent protection influence Colombia’s patent landscape?
    International filings via PCT or direct filings in Colombia can extend exclusivity, protect against generic entrants, and support global commercialization strategies.


References

  1. Colombian Patent Office (Superintendencia de Industria y Comercio). Official Patent Records.
  2. World Intellectual Property Organization. Patent Cooperation Treaty (PCT) System.
  3. European Patent Office. Guidelines and Patent Landscape Reports.
  4. National Institute of Industrial Property (INPI), Colombia. IP Landscape Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.